Association of Exon 19 and 21 EGFR Mutation Patterns With Treatment Outcome After First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31829f684a
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Elsevier BV